The global myocardial infarction market size was valued at USD 2.61 billion in 2025 and is projected to grow from USD 2.82 billion in 2026 to USD 5.22 billion by 2034, registering a CAGR of 8% during the forecast period from 2026 to 2034. North America dominated the myocardial infarction market with a market share of 39.2% in 2025.
Myocardial infarction (MI) is a medical term for a heart attack. It occurs when blood supply from the coronary artery to the heart muscle gets blocked due to plaque buildup, a substance made up of cholesterol and fats. Sudden chest pain, shortness of breath, anxiety, and sweating are some of the most of common symptoms of MI. People with high blood pressure, obesity, diabetes, smoking addiction, and a family history of heart attacks are more prone to myocardial infarction. Moreover, rising incidences of coronary artery diseases and changing lifestyles are the major contributors to the growing incidence of such as diseases. Electrocardiogram, blood tests, and coronary angiogram are a few major diagnostic tests used for detection of MI.
Download a Free Sample To learn more about this report,
Increasing Use of Multimodal Imaging for Myocardial Infarction Assessment
The myocardial infarction market is increasingly incorporating complementary imaging techniques to determine the underlying cause, extent, and consequences of myocardial injury. Cardiac magnetic resonance, echocardiography, coronary CT angiography, and invasive coronary imaging are being used alongside clinical assessment and biomarkers to improve characterization of myocardial infarction. This is shifting clinical practice toward more comprehensive anatomical and functional assessment rather than relying on a single diagnostic measurement.
Growing Emphasis on Personalized Secondary Prevention and Cardiac Rehabilitation
Post-myocardial-infarction care is increasingly emphasizing individualized secondary prevention and structured cardiac rehabilitation to reduce recurrent cardiovascular events and improve long-term recovery. Treatment programs are being tailored around medication adherence, exercise, lifestyle modification, risk-factor management, and patient-specific rehabilitation needs. This represents a shift in the myocardial infarction care pathway from acute hospital treatment toward longer-term management of cardiovascular risk and functional recovery.
Rising Burden of Cardiovascular Risk Factors and Coronary Disease
The myocardial infarction market is supported by the continuing burden of coronary artery disease and associated risk factors such as hypertension, diabetes, obesity, smoking, and dyslipidemia. These conditions increase the population at risk of acute coronary events and sustain demand for diagnostic testing, emergency treatment, revascularization, and secondary prevention. An aging population and increasing prevalence of multiple cardiovascular risk factors further expand the need for myocardial infarction management.
High Cost and Unequal Access to Advanced Acute Cardiac Care
Myocardial infarction treatment can require emergency hospitalization, cardiac catheterization, PCI, intensive monitoring, and long-term medication, creating substantial healthcare expenditure. Access to advanced cardiac facilities and specialist teams remains uneven across regions, particularly where emergency transport and catheterization infrastructure are limited. These differences can delay definitive treatment and restrict the adoption of advanced interventions in lower-resource healthcare systems.
Expansion of Remote Cardiac Rehabilitation and Post-Discharge Monitoring
Remote cardiac rehabilitation and digital follow-up create opportunities to extend myocardial infarction care beyond hospital-based programs. Home-based rehabilitation can combine remote monitoring, individualized exercise programs, medication support, and clinical follow-up, potentially improving participation among patients who face geographic or mobility barriers. This opportunity is focused on post-discharge care delivery rather than AI-based diagnosis or acute diagnostic technologies.
Reducing Treatment Delays Across the Acute Care Pathway
Rapid recognition and treatment remain challenging because myocardial infarction requires coordination among emergency services, diagnostic teams, cardiologists, catheterization laboratories, and hospital systems. Delays can occur between symptom onset, emergency presentation, diagnostic confirmation, risk assessment, and revascularization. Maintaining rapid and coordinated care is particularly difficult when patients present atypically or when healthcare systems have limited specialist and interventional capacity.
Antiplatelet Agents Dominated the Market with 24.8% Share in 2025
The antiplatelet agents segment accounted for the largest share of the global myocardial infarction market at 24.8% in 2025, driven by their critical role in preventing blood clot formation, reducing recurrent cardiovascular events, and improving outcomes in patients with acute coronary syndrome.
Thrombolytics and anti-thrombotic agents continue to witness strong demand due to their effectiveness in restoring blood flow during acute myocardial infarction. β adrenergic blockers remain widely prescribed for controlling heart rate, lowering blood pressure, and reducing the risk of subsequent cardiac events. Vasodilators are commonly used to improve coronary blood flow and relieve chest pain, while angiotensin converting enzyme inhibitors and angiotensin receptor antagonists play an important role in managing blood pressure and preventing heart failure after myocardial infarction. Analgesics continue to be utilized for pain management during acute cardiac episodes, whereas glycoprotein IIb/IIIa inhibitors are increasingly used in high-risk patients undergoing percutaneous coronary interventions.
Request Customizationto receive a tailored report.
Online Drug Stores are Projected to Register the Fastest Growth at a CAGR of 8.34%
The online drug stores segment is expected to expand at the highest CAGR of 8.34% during 2026–2034, supported by increasing adoption of e-pharmacy platforms, growing digital healthcare penetration, improved home delivery services, and rising patient preference for convenient access to cardiovascular medications.
Hospitals remain the leading distribution channel due to the high volume of emergency myocardial infarction treatments and inpatient care. Hospital pharmacies continue to play a vital role in ensuring timely availability of critical medications for acute and post-operative care, while drug stores maintain steady demand by providing prescription medicines for long-term cardiac disease management and follow-up treatment.
Speak to an Analystto discuss market opportunities.
North America market dominated the myocardial infarction market with a 39.2% share, valued at USD 1.02 billion in 2025. The region's leadership is driven by the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, increasing adoption of early diagnostic technologies, and strong availability of innovative treatment options. Rising healthcare expenditure, growing awareness of heart disease prevention, and continuous investments in cardiovascular research continue to support regional market growth.
The US market accounted for the largest share of the North American market in 2025. Growth is driven by increasing incidence of coronary artery disease, widespread access to advanced cardiac care, rising adoption of minimally invasive treatment procedures, and strong investments in cardiovascular research and drug development. Favorable reimbursement policies and the presence of leading pharmaceutical and medical device companies further strengthen the country's market position.
Canada market is witnessing steady market growth due to increasing awareness of cardiovascular health, expanding access to advanced diagnostic services, rising investments in cardiac care infrastructure, and growing adoption of evidence-based treatment protocols for myocardial infarction patients.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe market accounted for 27.4% of the global myocardial infarction market, reaching USD 0.72 billion in 2025, and is projected to register the fastest CAGR of 7.96% during the forecast period. Market growth is supported by increasing prevalence of cardiovascular disorders, expanding healthcare expenditure, growing adoption of advanced cardiac imaging technologies, and strong government initiatives promoting early diagnosis and preventive healthcare.
The United Kingdom market represents a significant market in Europe, driven by increasing investments in cardiovascular care, expanding access to emergency cardiac treatment, growing awareness of heart disease prevention, and rising adoption of advanced diagnostic and interventional procedures.
Germany market leads the European market owing to its advanced healthcare infrastructure, increasing adoption of innovative cardiovascular therapies, expanding investments in cardiac research, and strong availability of specialised heart care centres and emergency medical services.
Asia Pacific market accounted for 21.6% of the global myocardial infarction market, valued at USD 0.56 billion in 2025. The market is expanding due to the rising prevalence of cardiovascular diseases, growing ageing population, increasing healthcare investments, and improving access to advanced diagnostic and treatment facilities across emerging economies.
Japan market continues to experience steady market growth, supported by advanced healthcare infrastructure, increasing adoption of innovative cardiac treatment technologies, a rising elderly population, and growing emphasis on early diagnosis and preventive cardiovascular care.
The Chinese market accounted for the largest share of the Asia-Pacific market. Growth is supported by increasing incidence of cardiovascular diseases, expanding healthcare infrastructure, rising government investments in public healthcare, and growing adoption of advanced cardiac diagnostic and treatment solutions.
The Middle East & Africa market represented 5.0% of the global myocardial infarction market, totaling USD 0.13 billion in 2025. Rising prevalence of lifestyle-related cardiovascular diseases, improving healthcare infrastructure, increasing awareness of cardiac health, and expanding access to specialised cardiovascular care are supporting regional market growth.
The UAE market is a key market in the Middle East, driven by increasing investments in advanced healthcare facilities, growing adoption of modern cardiac diagnostic technologies, expanding emergency cardiovascular care services, and rising government initiatives promoting early disease detection.
The African market is witnessing gradual growth, supported by improving healthcare infrastructure, increasing awareness of cardiovascular diseases, expanding access to diagnostic and treatment services, and rising government and private investments in cardiac care. Countries such as South Africa, Egypt, and Kenya are creating long-term growth opportunities for market participants.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Alopecia Market Size, Share, Growth, Analysis, Report, 2034
Chemotherapy Market Size, Share, Growth, Analysis, Report, 2034
Acute Spinal Cord Injury Market Size, Share, Growth, Analysis, 2034
Anti-Acne Treatment Market Size, Share, Growth, Analysis, 2034
Acne Treatment Market Size, Share & Growth Graph by 2034
Aesthetic Medicine Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com